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tio of indirect costs is 6.3 / 2.3 billion SFr. Transfer costs
for disability payments are 37 million SFr per year (86%
for non-sport accidents).
CONCLUSIONS: Promotion of physical activity is cost
saving in terms of disease costs. Our findings regarding
the disease costs per patient are consistent with recently
published results for the US.
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OBJECTIVES: Prescribing errors are a major cause of ia-
trogenic morbidity in hospitalised patients and interven-
tions aimed at preventing these errors may result in mon-
etary benefits and health gains. We performed a study to
estimate whether costs of prevention are outweighed by
these benefits.
METHODS: During a one-week period in 2000, all med-
ication orders were analysed in two Dutch hospitals
(1100 beds in total) and prescribing errors were identi-
fied and classified. Medical and nursing staff were not
aware of the procedure. A cost-benefit analysis was per-
formed from the health-care perspective. Net cost esti-
mates were based on the time invested by the hospital
staff to correct the error and included potential time sav-
ings for the nursing staff. Estimates of net benefits were
based on the possible consequences of the prescribing er-
ror for nursing care, drug use, laboratory tests, length of
stay and potential interventions.
RESULTS: In total, 3540 medication orders were analy-
sed, of which 351 ( 10%) contained prescribing errors.
Classification of prescribing errors revealed that  60%
of errors would be without clinical consequences, whereas
 40% of errors would at least require extra monitoring
from the nursing staff. Net costs related to time invest-
ment of the pharmacy staff were  €300. Estimated net
benefits of this time investment were  €9900. These net
benefits were broken down as follows: extra care from
nursing staff of €300; extra drug use and laboratory tests
of €1900; extra length of hospital stay of €6000; acute
coronary intervention of €1700.
CONCLUSIONS: It can be concluded that net costs of
time investment by the pharmacy staff to prevent pre-
scribing errors were more than offset by related net bene-
fits.
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OBJECTIVE: To investigate the incidence of several
common chronic pathologies on the perceived quality of
life (PQL) in elderly outpatients ( 65 years), in Spain,
and its possible relation with the consumption of medi-
cines.
METHODS: A prospective analysis was carried out using
1500 questionnaires (Confidence limit 95%; Relative
error (/) 8%), following a protocol inspired in the
OARS design (Duke University). Subjects were chosen
following a stratified random design according to the
method of proportional fixation (geographical location,
age and sex). The survey was carried out by 17 social
workers, who received specific training.
RESULTS: 21 illnesses were determined, with varying de-
grees of prevalence in the population studied: arthritis
(57.4%); high blood pressure (30%); varicose veins
(23.3%); insomnia (21%); heart troubles (17%); bron-
chitis (14%), and diabetes (12%). Of the more prevalent
illnesses according to the subjects, those that most af-
fected PQL were heart troubles (70%), bronchitis (68%),
arthritis (65%), asthma (60%), diabetes (60%) and in-
somnia (45%). Of all the pathologies, a significant in-
crease in medicine consumption was found among pa-
tients in whom the illness was detrimental to their PQL,
as opposed to those who stated that they did not perceive
changes in their quality of life owing to the illness. Medi-
cine consumption was reported as follows: high blood
pressure (85% vs 22%); diabetes (78% vs 25%) and
asthma (72% vs 19%). Neither sex, age nor geographic
location affected these results significantly.
CONCLUSION: The results obtained show a remarkable
increase in the consumption of medicines in cases in
which the pathology and the subjective perception of the
illness affected their PQL. The increase was most notable
among patients in whom the illness affected their per-
ceived quality of life.
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OBJECTIVES: Older people are the largest consumers of
hospital care. They have longer hospital stays compared
to younger people. Reducing length of stay has become
an important feature of hospital treatment, but readmis-
sion is a common problem. We tried to identify medical,
social and demographic factors associated with readmis-
sion and suggest preventive measures to improve quality
of care of older people.
METHODS: A retrospective medical record review of a
random sample of 50 patients (aged  75 years) who had
unplanned readmission within 28 days of discharge
formed the study group. Another 50 patients who were
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not readmitted during the same period served as a con-
trol. Demographic, social and medical details were com-
pared between both groups.
RESULTS: No significant difference regarding age, gender,
sight, hearing, continence or mobility between both
groups. Living alone, with family, or residential care was
not significant. In the study group, 25 (50%) had five or
more weekly contacts with social services compared to 10
(20%) in the control (p  .001). Fourty (80%) of patients
who were readmitted had more than two co-morbidities
compared to 10 (20%) in the control group (p  .0001).
Heart failure was the most common readmission diagnosis
involving 18 (36%) of the study group and 6 (12%) of the
control (p  .001). Mean length of hospital stay was sig-
nificantly higher in the readmission group—21.06 days
compared to 13.44 days in control (p  .001). Most pa-
tients were readmitted within the first two weeks of dis-
charge (34 vs. 16) and the majority was for a relapse or
complication of the original condition (29 vs. 5).
CONCLUSIONS: Most readmissions are due to medical
factors. Risk groups are those with multiple co-morbidity
and/or who are dependent on social services. The major-
ity was due to relapse of the original condition, which
tends to present early. Patients with heart failure had
more readmissions than other patients with other comor-
bid diagnoses. Early review of high-risk patients may pre-
vent readmission.
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OBJECTIVE: To examine physician variation in admit-
ting patients to Intensive Care Units, using criteria re-
ported in the literature. Study Design: Prospective Survey.
Setting: randomly selected hospitals across Ontario, with
four or more ICU beds. Study Subjects: Physicians who
admit patients to the ICU from hospital emergency de-
partments. Interventions: None.
METHODS: We developed a survey based on 13 unique
scenarios in which were embedded varying risks includ-
ing: the complexity of the condition, acuteness of care re-
quired, and potential of survival. Variables that might in-
fluence physician’s decision to admit the patient to the
ICU were part of each response criteria. These included
age, the presence of advanced directives, patient and fam-
ily preferences, and availability of beds.
RESULTS: Out of 632 questionnaires sent out, 148 were
returned (23.4%). We found that patient age (33 yrs vs
73 yrs), presence of advanced directives and bed avail-
ability had a significant impact on admission decisions
(p  .001). Scenarios that implied an immediate need for
ICU intervention, higher probability of survival and ICU
staffing also had a significant impact on the decision (p 
.001). Irrespective of age, patients with no advanced di-
rectives were admitted to the ICU at the same rate as pa-
tients whose families asked that all measures be taken to
save the patient (p  .001).
CONCLUSIONS: Physician preferences, patient acute-
ness and ICU resource availability influence admission
decisions to the ICU. This finding is interesting consider-
ing that most physicians do not elicit advanced directives
from patients or their caregivers prior to an ICU admis-
sion. However, physicians’ responses indicate that ad-
vanced directives is the most important factor influencing
admission. The opportunity to utilize these findings in
the development of guidelines for ICU admissions will
form part of our ongoing research.
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OBJECTIVES: To compare the cost per day of one pa-
tient (from 1000 inhabitants) exposure to 5 drug groups.
METHODS: Data have been collected from: a) the im-
port of wholesalers, b) the local industry sale reports for
the domestic market. Drug consumption has been ex-
pressed by means of ATC/DDD methodology for the
groups A (Alimentary), C (Cardiovascular), J (General
antiinfectives), N (Nervous), R (Respiratory). Drug con-
sumption for the same groups has been expressed in
terms of cost in BGN. The cost of one patient (from 1000
inhabitants) exposure per day to a certain drug group has
been calculated for each one of the selected groups.
RESULTS: Drug consumption in DDD/1000/day: A—
91.5, C—127.2, J—17.1, N—55.0 and R—30.8 in 1999,
and 104.4, 114.0, 21.7, 70.9, and 19.7 in 2000, respec-
tively. The cost in pecuniary units /mil. BGN correspond-
ing to the above mentioned values: 40.43; 50.13; 38.81;
42.05, and 22.64 in 1999, and 42.40, 37.67, 55.88,
51.36, and 21.14 in 2000, respectively. Cost of drug ex-
posure of one patient from 1000 (in mil. BGN): A—0.44;
C—0.39; J—2.27; N—0.76, and R—0.74 in 1999, and
0.41, 0.33, 2.58, 0.72, and 1.07 in 2000, respectively. Al-
though group C has shown highest consumption in terms
of cost and DDD/1000/day it has shown the lowest value
in terms of cost of drug exposure for one patient. Group J
shows the highest value in terms of cost of drug exposure
for one patient, although its consumption measured by
cost in BGN and in DDD/1000/day is in fourth and fifth
place, respectively.
CONCLUSIONS: Cost of drug exposure for one patient
analysis is a more reliable indicator than the cost analysis
of sales. It may be used by drug policy makers as it mea-
sures drug expenditures under standardized conditions.
